Producing better and safer medicines through artificial oligonucleotide DNA aptamer technology
TAGCyx Bio can create DNA aptamers through drug discovery platform technology “Xenoligo®” based on innovative artificial base pairing technology. Aptamers are the next generation drug modality consisting of single-stranded oligonucleotide molecules. We will produce more effective and safer medicines and medical devices and contribute to society by delivering therapies to as many people as possible at low cost.
- We can create superior oligonucleotide aptamers, Xenoligo®, using our world-leading proprietary artificial base pairing technology.
- By creating oligonucleotide aptamers, which are chemical antibodies that can replace antibody drugs, we can reduce side effects, diversify administration routes, and contribute to the improvement of healthcare economics.
- oligonucleotide aptamers can be applied to medical devices such as apheresis and diagnostic reagents to create products that outperform existing technologies.